<VariationArchive RecordType="classified" VariationID="599276" VariationName="NM_003106.4(SOX2):c.385_386del (p.Gly129fs)" VariationType="Deletion" Accession="VCV000599276" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-26" DateCreated="2019-01-11" MostRecentSubmission="2019-01-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="590520" VariationID="599276">
      <GeneList>
        <Gene Symbol="LOC108281177" FullName="SOX2 5' regulatory region" GeneID="108281177" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181707848" stop="181712914" display_start="181707848" display_stop="181712914" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SOX2" FullName="SRY-box transcription factor 2" GeneID="6657" HGNC_ID="HGNC:11195" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181711925" stop="181714436" display_start="181711925" display_stop="181714436" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181429711" stop="181432223" display_start="181429711" display_stop="181432223" Strand="+" />
          </Location>
          <OMIM>184429</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX2">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SOX2-OT" FullName="SOX2 overlapping transcript" GeneID="347689" HGNC_ID="HGNC:20209" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>3q26.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181056680" stop="181742228" display_start="181056680" display_stop="181742228" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181328150" stop="181459008" display_start="181328150" display_stop="181459008" Strand="+" />
          </Location>
          <OMIM>616338</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003106.4(SOX2):c.385_386del (p.Gly129fs)</Name>
      <CanonicalSPDI>NC_000003.12:181712744:GG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q26.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="181712745" stop="181712746" display_start="181712745" display_stop="181712746" variantLength="2" positionVCF="181712744" referenceAlleleVCF="CGG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="181430533" stop="181430534" display_start="181430533" display_stop="181430534" variantLength="2" positionVCF="181430532" referenceAlleleVCF="CGG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>G129fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_719" sequenceAccession="LRG_719" change="g.5812_5813del">
            <Expression>LRG_719:g.5812_5813del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.181430533_181430534del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.181430533_181430534del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.181712745_181712746del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.181712745_181712746del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009080.1" sequenceAccession="NG_009080" sequenceVersion="1" change="g.5812_5813del">
            <Expression>NG_009080.1:g.5812_5813del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003106.4" sequenceAccession="NM_003106" sequenceVersion="4" change="c.385_386del" MANESelect="true">
            <Expression>NM_003106.4:c.385_386del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003097.1" sequenceAccession="NP_003097" sequenceVersion="1" change="p.Gly129fs">
            <Expression>NP_003097.1:p.Gly129fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1560264452" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="protein truncation">
        <XRef ID="0015" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003106.4(SOX2):c.385_386del (p.Gly129fs) AND Anophthalmia/microphthalmia-esophageal atresia syndrome" Accession="RCV000735864" Version="1">
        <ClassifiedConditionList TraitSetID="3485">
          <ClassifiedCondition DB="MedGen" ID="C1859773">Anophthalmia/microphthalmia-esophageal atresia syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-08-31" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-08-31" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-01-11" MostRecentSubmission="2019-01-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3485" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5530" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Microphthalmia and esophageal atresia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia clinical with associated anomalies</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia esophageal genital syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">AEG syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Anophthalmia microphthalmia esophageal atresia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Anophthalmia/microphthalmia-esophageal atresia syndrome</ElementValue>
                <XRef ID="MONDO:0008799" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Microphthalmia syndromic 3</ElementValue>
                <XRef ID="Microphthalmia+syndromic+3/4787" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MCOPS3</ElementValue>
                <XRef Type="MIM" ID="206900" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 anophthalmia syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-related eye disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2-Related Eye Disorders</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1443" />
                <XRef ID="1443" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of SOX2 disorder includes anophthalmia and/or microphthalmia, brain malformations, developmental delayÂ / intellectual disability, esophageal atresia, hypogonadotropic hypogonadism (manifest as cryptorchidism and micropenis in males, gonadal dysgenesis infrequently in females, and delayed puberty in both sexes), pituitary hypoplasia, postnatal growth delay, hypotonia, seizures, and spastic or dystonic movements.</Attribute>
                <XRef ID="NBK1300" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SOX2 Disorder</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301477</ID>
                <ID Source="BookShelf">NBK1300</ID>
              </Citation>
              <XRef ID="77298" DB="Orphanet" />
              <XRef ID="C1859773" DB="MedGen" />
              <XRef ID="MONDO:0008799" DB="MONDO" />
              <XRef Type="MIM" ID="206900" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1689796" SubmissionDate="2019-01-03" DateLastUpdated="2019-01-11" DateCreated="2019-01-11">
        <ClinVarSubmissionID localKey="SUB5000246" submittedAssembly="GRCh38" title="SUB5000246" />
        <ClinVarAccession Accession="SCV000863977" DateUpdated="2019-01-11" DateCreated="2019-01-11" Type="SCV" Version="1" SubmitterName="Division of Critical Care, Department of Pediatrics, Cardinal Glennon Children's Hospital" OrgID="506819" OrganizationCategory="other" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-31">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment Type="public">This is the first report of the p.Gly129Argfs*9 variant in SOX2. The patient has all the typical features of syndromic microphthlamia including bilateral anophthalmia and developmental delay and is heterozygous for this mutation. Previous reports of SOX2-related anopthlamia syndrome have shown an autosomal dominant pattern. The early frameshift with early termination codon would be predicted to result in loss of function from this allele.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>Hispanic</Ethnicity>
              <GeographicOrigin>United States</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <NamePlatform>ABI 3730xl</NamePlatform>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <Description>Per Prevention Genetics Report: DNA was extracted from the patient specimen using a 5 Prime ArchivePure DNA Blood Kit. PCR was used to amplify the indicated exons puls additional flanking intronic or other non-coding sequence. After cleaning of the PCR products, cycle sequencing was carried out using the ABI Big Dye Terminator v.3.0 kit. Products were resolved by electrophoresis on an ABI 3730xl capillary sequencer. Sequencing was performed separately in both the forward and reverse directions.</Description>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="TestName">genomic DNA sequencing</Attribute>
              </MethodAttribute>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory" dateValue="2014-04-09">Prevention Genetics</Attribute>
                <Comment Type="public">Pathogenic</Comment>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet DateLastEvaluated="2016-10-13" Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000528" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0012758" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0008245" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000824" />
              </Trait>
              <Comment Type="public">MRI on day 1 of life confirmed absence of globes and no identified optic nerves or optic chiasm. Brain otherwise is structurally normal. Hypothyroidism and growth hormone deficiency diagnosed by clinical testing at 17 months of age performed based on previous case series of SOX2 anophthalmia patients having similar abnormalities. Thyroid hormones were normal in early infancy. Developmental delay is global and severe. At age 4 she does not speak and is unable to perform simple controlled movements. She does not eat by mouth. She does not sit unsupported, pull up, or walk.</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX2">
              <Name>SRY-box 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_003106.3:exon 1</GeneLocation>
          </Location>
          <FunctionalConsequence Value="protein truncation" />
          <AttributeSet>
            <Attribute Type="HGVS">NM_003106.3:c.385_386delGG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="206900" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5000246</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1689796" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000528" MappingRef="HP">
        <MedGen CUI="C0003119" Name="Anophthalmia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1689796" TraitType="Disease" MappingType="XRef" MappingValue="206900" MappingRef="OMIM">
        <MedGen CUI="C1859773" Name="Anophthalmia/microphthalmia-esophageal atresia syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1689796" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000824" MappingRef="HP">
        <MedGen CUI="C5539399" Name="Decreased response to growth hormone stimulation test" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1689796" TraitType="Finding" MappingType="XRef" MappingValue="HP:0008245" MappingRef="HP">
        <MedGen CUI="C3665349" Name="Pituitary hypothyroidism" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1689796" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012758" MappingRef="HP">
        <MedGen CUI="C4022738" Name="Neurodevelopmental delay" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

